Synthesis and in Vitro Antioxidant Activity of Glycyrrhetinic Acid Derivatives Tested with the Cytochrome P450/NADPH System
作者:Mourboul Ablise、Brigitte Leininger-Muller、Choi Dal Wong、Gérard Siest、Vincent Loppinet、Sophie Visvikis
DOI:10.1248/cpb.52.1436
日期:——
Five glycyrrhetinic acid (Ib) derivatives have been synthesized to try to improve the antioxidant activity. Their in vitro antioxidant activities were studied using a cytochrome P450/NADPH reductase system from rat liver microsomes. The generation of microsomal free radicals was followed by oxidation of the DCFH-DA probe, while evaluating the capacity to inhibit reactive oxygen species (ROS) formation. Two hydroxylated derivatives, 18β-olean-12-ene-3β,11α,30-triol (II) and 18β-olean-12-ene-3β,11β,30-triol (IV), exhibited strong antioxidant activities. At a concentration of 1.0 mg/ml, these derivatives inhibited ROS formation by 50% and 51%, respectively. Moreover, two homo- and heterocyclic diene derivatives, 18β-olean-11,13(18)-diene-3β,30-diol (III) and 18β-olean-9(11),12-diene-3β,30-diol (V), were also effective in ROS-scavenging activity (inhibition of 41% and 44% of ROS activity, respectively). In the same conditions, the lead compound (Ib) and the reference vitamin E inhibited ROS activity by 31% and 32%, respectively. Our results suggest that the chemical reduction of the 11-keto and 30-carboxyl groups into hydroxyl function (example, II, IV) can increase the antioxidant activity of Ib significantly. In view of these results, our study represents a further approach to the development of potential therapeutic agents from Ib derivatives for use in pathologic events in which, free radical damage could be involved.
为了提高抗氧化活性,我们合成了五种甘草次酸(Ib)衍生物。我们利用大鼠肝脏微粒体的细胞色素 P450/NADPH 还原酶系统研究了它们的体外抗氧化活性。微粒体自由基的生成是通过 DCFH-DA 探针的氧化进行的,同时还评估了抑制活性氧(ROS)形成的能力。18β-olean-12-ene-3β,11α,30 三醇(II)和 18β-olean-12-ene-3β,11β,30 三醇(IV)这两种羟基化衍生物表现出很强的抗氧化活性。在 1.0 毫克/毫升的浓度下,这些衍生物对 ROS 形成的抑制率分别为 50%和 51%。此外,18β-烯-11,13(18)-二烯-3β,30-二醇(III)和 18β-烯-9(11),12-二烯-3β,30-二醇(V)这两种同环和杂环二烯衍生物也具有有效的 ROS 清除活性(分别抑制了 41% 和 44% 的 ROS 活性)。在相同条件下,先导化合物(Ib)和参考维生素 E 对 ROS 活性的抑制率分别为 31% 和 32%。我们的研究结果表明,将 11-酮基和 30-羧基化学还原成羟基功能(例如,II、IV)可以显著提高 Ib 的抗氧化活性。鉴于这些结果,我们的研究为开发 Ib 衍生物的潜在治疗药物提供了进一步的思路,这些药物可用于可能涉及自由基损伤的病理事件。